Los puntos clave no están disponibles para este artículo en este momento.
This review considers recent evidence concerning hypertension management in patients with chronic obstructive pulmonary disease, including the effects of antihypertensive-drug classes on exacerbations, hospitalizations, and adverse pulmonary outcomes.
Finks et al. (Wed,) studied this question.